US Biopharma Analyst Courtney Breen joins host Diana Wood to discuss the evolution of GLP-1 therapies for obesity, focusing on the transformative impact of oral formulations and recent policy changes that expand access. We explore market dynamics, patient demographics, and the future landscape of obesity treatment. Hosted on Acast. See acast.com/privacy for more information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from In the Know
Alex Irving: European Airlines, Ready for Take Off
Live from the Nice Conference: Reto Suter, CFO of Siegfried
Live from the Nice Conference: Gerrit Steen, CFO of AT&S
Live from the Nice Conference: Ian Malin, CCO of Wizz Air
Get summaries like this every morning.
Free AI-powered recaps of In the Know and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.